Clinical Trial Update: Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease Symptoms [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Cannabidiol (Kanbis) for Parkinson disease symptoms is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Kanbis (cannabidiol)

Snippet

Sponsor: Laboratorio Elea Phoenix S.A. | Conditions: Parkinson Disease | Phase 2 | Status: RECRUITING